Dr. Reddy's to Release Q3 FY11 Results on January 25, 2011

Earnings call slated for January 25, 6:30 PM IST / 8.00 AM EST

HYDERABAD, India--()--Dr. Reddy's Laboratories (NYSE:RDY) will announce results for the Third Quarter ended December 31, 2010 on Tuesday, January 25th 2011 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com

Summary of Events

Event

 

Date and Time (IST)

 

Medium

Release of financial results   January 25, after the Board Meeting   Email, Media, Company website, Businesswire
Earnings Call   January 25, 6:30 PM IST / 8:00 AM EST   Hosted by the Company (Details below)
Webcast of Earnings Call   January 25, 6:30 PM IST / 8:00 AM EST through January 30, 2011  

URL available on Company’s website,

www.drreddys.com

Transcripts of the Earnings call   Will be available on the Company’s website  

URL available on Company’s website,

www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Conference Dial-In Numbers

Primary Number:   +91 22 3065 0136
Secondary Number:   +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:  

6000 1221
Available in - Delhi, Bangalore, Chennai, Hyderabad, Kolkata
Accessible from all major carriers except BSNL/MTNL.

 

3940 3977
Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune, Lucknow, Ahmedabad, Chandigarh Accessible from all carriers.

International Toll

Free Number:

 

USA: 1 866 746 2133 // UK: 0 808 101 1573

 

Singapore: 800 101 2045 // Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through January 30, 2011. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is a global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Our products are marketed globally, with a focus on India, US, UK, Germany and Russia.

Contacts

Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
Raghavender R, +91 40 66511529
raghavenderr@drreddys.com
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com

Contacts

Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
Raghavender R, +91 40 66511529
raghavenderr@drreddys.com
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com